(Q30451318)

English

In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus

scientific article published on August 1, 1984

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus (English)

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

methicillin-resistant Staphylococcus aureus

0 references

0 references

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

1 reference

10.1128/AAC.26.2.268

https://api.crossref.org/works/10.1128/AAC.26.2.268

4 September 2023

author name string

S. H. Guenthner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237606

4 September 2023

R. P. Wenzel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237606

4 September 2023

language of work or name

0 references

publication date

1 August 1984

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

full work available at URL

https://europepmc.org/articles/PMC284135

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237606

4 September 2023

https://europepmc.org/articles/PMC284135?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237606

4 September 2023

https://journals.asm.org/doi/pdf/10.1128/AAC.26.2.268

1 reference

10.1128/AAC.26.2.268

https://api.crossref.org/works/10.1128/AAC.26.2.268

4 September 2023

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

26

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

268-269

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Fucidin: a new orally active antibiotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Variable Tolerance of a Clinical Isolate of <i>Staphylococcus epidermidis</i> from an Infected Hydrocephalus Shunt for Several <i>%beta;</i>-Lactam Antibiotics, Vancomycin and Fosfomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Fusidic acid: new opportunities with an old antibiotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Interpretation of Diffusion Susceptibility Data Obtained with 10-<i>μ</i>g Fucidin (Sodium Fusidate) Disks against Clinical Isolates of <i>Staphylococcus aureus</i>

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

The mechanism of action of fosfomycin (phosphonomycin)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Fucidin-Resistant Staphylococci in Current Hospital Practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Flucloxacillin in the treatment of infectious conditions in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Activity of fosfomycin in the treatment of bacterial infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Bacteriological evaluation of fosfomycin in clinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Flucloxacillin in bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

20 June 2018

Failure to prevent emergence of bacterial resistance by combination of two antibiotics: fusidic acid and rifampicin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284135

26 November 2018

Methicillin-resistant staphylococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/6237606

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin in chronic urinary infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/6237606

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The emergence of methicillin-resistant Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/6237606

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International recognition of methicillin-resistant strains of Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/6237606

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial activity in vitro of fucidin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6237606

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.26.2.268

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30451318&oldid=1968502105"